Julian G. Hurdle

3.5k total citations · 1 hit paper
58 papers, 2.6k citations indexed

About

Julian G. Hurdle is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Julian G. Hurdle has authored 58 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 23 papers in Molecular Biology and 17 papers in Epidemiology. Recurrent topics in Julian G. Hurdle's work include Clostridium difficile and Clostridium perfringens research (32 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Helicobacter pylori-related gastroenterology studies (11 papers). Julian G. Hurdle is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (32 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Helicobacter pylori-related gastroenterology studies (11 papers). Julian G. Hurdle collaborates with scholars based in United States, United Kingdom and Germany. Julian G. Hurdle's co-authors include Richard Lee, Ian Chopra, Alex J. O’Neill, Xiaoqian Wu, Dianqing Sun, Robin B. Lee, Kirk E. Hevener, Kevin W. Garey, Philip Cherian and Min Dong and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Julian G. Hurdle

57 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections

2010 673 citations Julian G. Hurdle, Richard Lee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julian G. Hurdle United States	28	1.2k	1.1k	498	444	397	58	2.6k
Sanjib Bhakta United Kingdom	33	1.3k 1.1×	1.1k 1.0×	548 1.1×	666 1.5×	95 0.2×	100	2.7k
Sidharth Chopra India	28	1.0k 0.9×	702 0.7×	880 1.8×	363 0.8×	232 0.6×	209	2.5k
Yusuf Akhter India	27	1.3k 1.1×	460 0.4×	233 0.5×	499 1.1×	169 0.4×	150	2.4k
Dean L. Shinabarger United States	27	1.7k 1.4×	1.5k 1.4×	377 0.8×	446 1.0×	177 0.4×	48	3.5k
Haroon Mohammad United States	27	899 0.7×	618 0.6×	690 1.4×	243 0.5×	414 1.0×	40	1.9k
Anand Anbarasu India	31	1.4k 1.1×	372 0.4×	235 0.5×	356 0.8×	150 0.4×	167	2.7k
Liliana Rodrigues Portugal	23	761 0.6×	898 0.8×	237 0.5×	664 1.5×	79 0.2×	43	1.9k
Dmitri Debabov United States	19	620 0.5×	559 0.5×	217 0.4×	212 0.5×	215 0.5×	42	1.5k
Shankar Thangamani United States	23	762 0.6×	606 0.6×	359 0.7×	288 0.6×	246 0.6×	48	1.7k
Noton K. Dutta United States	31	1.1k 0.9×	1.3k 1.2×	240 0.5×	791 1.8×	82 0.2×	101	2.9k

Countries citing papers authored by Julian G. Hurdle

Since Specialization

Citations

This map shows the geographic impact of Julian G. Hurdle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian G. Hurdle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian G. Hurdle more than expected).

Fields of papers citing papers by Julian G. Hurdle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julian G. Hurdle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian G. Hurdle. The network helps show where Julian G. Hurdle may publish in the future.

Co-authorship network of co-authors of Julian G. Hurdle

This figure shows the co-authorship network connecting the top 25 collaborators of Julian G. Hurdle. A scholar is included among the top collaborators of Julian G. Hurdle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian G. Hurdle. Julian G. Hurdle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hurdle, Julian G., et al.. (2025). The microbiome-restorative potential of ibezapolstat for the treatment of Clostridioides difficile infection is predicted through variant PolC-type DNA polymerase III in Lachnospiraceae and Oscillospiraceae. Antimicrobial Agents and Chemotherapy. 69(4). e0167924–e0167924. 1 indexed citations

Le, Trang, et al.. (2024). Fidaxomicin resistance in Clostridioides difficile : a systematic review and predictive modeling with RNA polymerase binding sites. Antimicrobial Agents and Chemotherapy. 68(12). e0120624–e0120624. 3 indexed citations

Eubank, Taryn A, Chetna Dureja, Anne J Gonzales-Luna, Julian G. Hurdle, & Kevin W. Garey. (2024). Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes. Open Forum Infectious Diseases. 11(11). ofae588–ofae588. 3 indexed citations

Eubank, Taryn A, Chetna Dureja, Kevin W. Garey, Julian G. Hurdle, & Anne J Gonzales-Luna. (2024). Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response. Clinical Infectious Diseases. 79(1). 15–21. 14 indexed citations

Marreddy, Ravi K. R., Reid T. Powell, Philip Cherian, et al.. (2024). Chemical genetic analysis of enoxolone inhibition of Clostridioides difficile toxin production reveals adenine deaminase and ATP synthase as antivirulence targets. Journal of Biological Chemistry. 300(11). 107839–107839.

Dureja, Chetna, et al.. (2024). Evaluation of Fusobacterium nucleatum Enoyl-ACP Reductase (FabK) as a Narrow-Spectrum Drug Target. ACS Infectious Diseases. 10(5). 1612–1623. 3 indexed citations

Dureja, Chetna, et al.. (2023). Synthesis and evaluation of phenylimidazole FabK inhibitors as new Anti-C. Difficile agents. Bioorganic & Medicinal Chemistry. 88-89. 117330–117330. 3 indexed citations

Manion, John, Melissa A. Musser, Min Liu, et al.. (2023). C. difficile intoxicates neurons and pericytes to drive neurogenic inflammation. Nature. 622(7983). 611–618. 35 indexed citations

Marreddy, Ravi K. R., et al.. (2021). Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing. Microbiology Spectrum. 9(2). e0044821–e0044821. 11 indexed citations

10.

Wu, Xiaoqian, et al.. (2020). Chromosomal Resistance to Metronidazole in Clostridioides difficile Can Be Mediated by Epistasis between Iron Homeostasis and Oxidoreductases. Antimicrobial Agents and Chemotherapy. 64(8). 26 indexed citations

11.

Prior, Allan M., et al.. (2019). Small-Molecule Inhibition of the C. difficile FAS-II Enzyme, FabK, Results in Selective Activity. ACS Chemical Biology. 14(7). 1528–1535. 9 indexed citations

12.

Cherian, Philip, et al.. (2016). Design, synthesis and microbiological evaluation of ampicillin–tetramic acid hybrid antibiotics. The Journal of Antibiotics. 70(1). 65–72. 15 indexed citations

13.

Rakesh, Rakesh, David F. Bruhn, Michaël Scherman, et al.. (2014). Pentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosis. PLoS ONE. 9(2). e87909–e87909. 29 indexed citations

14.

Li, Feng, Marcus M. Maddox, Gagandeep Narula, et al.. (2014). Synthesis, Structure–Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin A and Derivatives. Journal of Medicinal Chemistry. 57(20). 8398–8420. 94 indexed citations

15.

Wu, Xiaoqian, et al.. (2013). Prospects for flavonoid and related phytochemicals as nature-inspired treatments for Clostridium difficile infection. Journal of Applied Microbiology. 116(1). 23–31. 22 indexed citations

16.

Budha, Nageshwar, Robin B. Lee, Julian G. Hurdle, Richard Lee, & Bernd Meibohm. (2009). A simple in vitro PK/PD model system to determine time–kill curves of drugs against Mycobacteria. Tuberculosis. 89(5). 378–385. 28 indexed citations

17.

Hurdle, Julian G., Raghunandan Yendapally, Dianqing Sun, & Richard Lee. (2009). Evaluation of Analogs of Reutericyclin as Prospective Candidates for Treatment of Staphylococcal Skin Infections. Antimicrobial Agents and Chemotherapy. 53(9). 4028–4031. 22 indexed citations

18.

Sun, Dianqing, Michaël Scherman, Victoria Jones, et al.. (2009). Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity. Bioorganic & Medicinal Chemistry. 17(10). 3588–3594. 20 indexed citations

19.

Yendapally, Raghunandan, et al.. (2008). N-Substituted 3-Acetyltetramic Acid Derivatives as Antibacterial Agents. Journal of Medicinal Chemistry. 51(5). 1487–1491. 39 indexed citations

20.

Hurdle, Julian G.. (2003). The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden. Journal of Antimicrobial Chemotherapy. 53(1). 102–104. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact